<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136165">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01898780</url>
  </required_header>
  <id_info>
    <org_study_id>HOMING</org_study_id>
    <nct_id>NCT01898780</nct_id>
  </id_info>
  <brief_title>Horizontal Mattress vs. Interrupted Suture in Surgical Techniques of Pancreaticojejunostomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wakayama Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wakayama Medical University</source>
  <oversight_info>
    <authority>Japan: Ministry of Health, Labor and Welfare</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to verify that the frequency of pancreatic fistula (ISGPF grade B
      and C) in horizontal mattress suture are lower than in interrupted suture during
      pancreaticojejunostomy in pancreatoduodenectomy by randomized clinical trial.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The frequency of pancreatic fistula including ISGPF grade B and C</measure>
    <time_frame>Ninety days after operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rates of postoperative complications</measure>
    <time_frame>Ninety days after operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Patients Who Undergo Pancreatoduodenectomy</condition>
  <arm_group>
    <arm_group_label>horizontal mattress</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pancreaticojejunostomy with horizontal mattress suture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>interrupted suture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pancreaticojejunostomy with interrupted suture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreaticojejunostomy with horizontal mattress suture</intervention_name>
    <arm_group_label>horizontal mattress</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreaticojejunostomy with interrupted suture</intervention_name>
    <arm_group_label>interrupted suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients from whom we obtained written informed consent of this study

        Exclusion Criteria:

          -  Patients with severe ischemic cardiac disease

          -  Patients with severe liver damage

          -  Patients requiring oxygen administration due to interstitial pneumonia or pulmonary
             fibrosis

          -  Patients requiring dialysis treatment due to chronic renal failure

          -  Patients who are considered as inappropriate by attending physician
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Second Department of Surgery, Wakayama Medical University</name>
      <address>
        <city>Wakayama</city>
        <zip>641-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 12, 2013</lastchanged_date>
  <firstreceived_date>July 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wakayama Medical University</investigator_affiliation>
    <investigator_full_name>Hiroki Yamaue</investigator_full_name>
    <investigator_title>Second Department of Surgery</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
